Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Eczema-wise logo link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.
 

Search Results for “dupilumab”


Dupilumab efficacy and safety in pediatric patients with AD >6 and <18 years

Read More


A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

Following on the heels of Dupixent (dupilumab)—the first-ever biologic drug for atopic dermatitis (the most common type of eczema), approved by the U.S. Food and Drug Administration (FDA) on March 28—a second biologic may soon be on the way.

Read More


NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

ICER, a nonprofit that conducts independent reviews on clinical effectiveness and value of treatments, found Dupixent to be a “high value” drug for adults with atopic dermatitis.

Read More


Spotlight: Never Lose Hope

A newly approved treatment finally brings relief to a woman who’s coped with severe eczema for more than 70 years.

Read More


Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis. Clinical research investigator Dr Paul Yamauchi answers questions about the new medication.

Read More


First Biologic Approved for Moderate to Severe Atopic Dermatitis

The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moderate to severe atopic dermatitis (AD).

Read More


Biologics

What are biologics? Biologic drugs, or “biologics,” are among the most targeted therapies available today because they essentially use human DNA to treat certain diseases at the immune system level. Taken subcutaneously (through the skin) or intravenously (in the vein), biologics are genetically engineered medications that contain proteins derived from living tissues or cells cultured […]

Read More


American Academy of Dermatology 2017 Annual Meeting Highlights

Atopic dermatitis is a hot field of study. Here’s some highlights on eczema research and care from this year’s AAD meeting.

Read More


Hope With New Atopic Dermatitis Drugs But Will They Be Covered?

As more treatments for AD are approved by the FDA, your health insurance company may restrict your ability to access new drugs in order to control costs. The following are some of the most common tactics health insurance companies use to restrict access to certain treatments and medical care.

Read More


Understanding Biologic Drugs

Biologic medications are already being used to treat diseases including rheumatoid arthritis, psoriasis and Crohn’s disease, as well as others. So, what are biologic drugs and what do people need to know if they are considering them to treat their AD?

Read More